Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older …

PE Castle, MH Stoler, TC Wright, A Sharma… - The lancet …, 2011 - thelancet.com
Background The ATHENA study was designed to assess the performance of carcinogenic
human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping compared with liquid …

Human papillomavirus: science and technologies for the elimination of cervical cancer

FX Bosch - Expert opinion on pharmacotherapy, 2011 - Taylor & Francis
Introduction: Academic research has made a significant advancement in understanding the
viral causes of cervical cancer and generating the technology for prevention, both at the …

Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976–2005: an age–period–cohort analysis

PK Dhillon, BB Yeole, R Dikshit, AP Kurkure… - British journal of …, 2011 - nature.com
Background: Demographic, socioeconomic and cultural changes in India have increased
longevity, delayed childbearing, decreased parity and resulted in a more westernised …

A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB–IIA

YY Lee, CH Choi, TJ Kim, JW Lee, BG Kim, JH Lee… - Gynecologic …, 2011 - Elsevier
OBJECTIVE: This study was designed to investigate the survival difference between pure
adenocarcinoma (AC) and squamous cell carcinoma (SCC) in early cervical cancer (FIGO …

Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix

ML Tornesello, S Losito, G Benincasa, F Fulciniti… - Gynecologic …, 2011 - Elsevier
OBJECTIVE: Human papillomavirus (HPV) genotypes have been extensively studied in
uterine cervix squamous cell carcinoma and HPV16 variants have been found to be …

Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California

PE Castle, R Shaber, BJ LaMere, W Kinney… - … , biomarkers & prevention, 2011 - AACR
Background: The human papillomavirus (HPV) Persistence and Progression Cohort is a
natural history study of carcinogenic HPV positive women. Here, we present the HPV …

Position paper—HPV and the primary prevention of cancer; improving vaccine uptake by paediatricians

J Ramet, D van Esso, Z Meszner… - European journal of …, 2011 - Springer
A large proportion of sexually active adults are infected with the human papillomaviruses
(HPVs). Although largely asymptomatic, some types of HPVs (HPV-16, HPV-18) which infect …

Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice

W Kinney, B Fetterman, JT Cox, T Lorey… - Gynecologic …, 2011 - Elsevier
OBJECTIVE: To characterize the cervical cancers diagnosed following a Pap-negative, high
risk human papillomavirus (HPV)-positive (Pap−/HPV+) screen in routine clinical practice …

Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine

KA Ault, EA Joura, SK Kjaer, OE Iversen… - … journal of cancer, 2011 - Wiley Online Library
The primary objective of this report is to describe the detection of adenocarcinoma in situ
(AIS) and associated human papillomavirus (HPV) type distribution that was observed in the …

Prevalence of human papillomavirus (HPV) types in cervical cancer 2003–2008 in Stockholm, Sweden, before public HPV vaccination

J Du, A Näsman, JW Carlson, T Ramqvist… - Acta …, 2011 - Taylor & Francis
Background. Human papillomavirus (HPV) infection is the major cause of cervical cancer,
but the prevalence of different HPV types varies depending on geographical location and …